In a challenging market environment, DFLI, the stock for Chardan Nextech Acquisition 2, has reached a 52-week low, dipping to $2.49. According to InvestingPro analysis, the company's financial health ...
Chardan Capital Markets has recently initiated Mind Medicine (MindMed) Inc (MNMD) stock to Buy rating, as announced on December 20, 2024, according to Finviz. Earlier, on October 14, 2024, Leerink ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback